(2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Suppliers list
|
|
| (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Basic information |
Product Name: | (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid | Synonyms: | (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid;3beta-Hydroxy-24-methylene-8-lanosten-21-oic acid;Eburcoic acid;NSC 41969;Eburicoic acid
3β-Hydroxy-24-methylene-8-lanosten-21-oic acid;Eburicoicaci;Lanost-8-en-21-oic acid, 3-hydroxy-24-methylene-, (3β)-;Eburicoic acid
3β-Hydroxy-24-methylene-8-lanosten-21-oic acid | CAS: | 560-66-7 | MF: | C31H50O3 | MW: | 470.74 | EINECS: | | Product Categories: | Natural metabolites | Mol File: | 560-66-7.mol | |
| (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Chemical Properties |
Melting point | 283 °C | Boiling point | 572.6±50.0 °C(Predicted) | density | 1.05±0.1 g/cm3(Predicted) | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | form | Powder | pka | 4.65±0.10(Predicted) | color | White to off-white |
| (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Usage And Synthesis |
Uses | Eburicoic Acid can be useful in the study of constituents from fruiting bodies of Trametes cubensis and Trametes suaveolens in Vietnam and their anti-inflammatory bioactivity. | target | SOD | NO | TNF-α | NOS | COX | P450 (e.g. CYP17) | IL Receptor |
| (2R)-2-[(3S,5S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3 ,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-m ethyl-5-methylidene-heptanoic acid Preparation Products And Raw materials |
|